Evaluating vonoprazan bismuth-containing triple therapy versus quadruple therapy for Helicobacter pylori

被引：0
|
作者：
Tang, W-Z [1 ]
Li, J-Z [1 ]
Liu, T-H [1 ]
机构：
[1] Chongqing Med Univ, Sch Basic Med Sci, Dept Bioinformat, Chongqing, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2024年
关键词：
D O I：
10.1111/jgh.16753
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
    Huh, Ki Young
    Chung, Hyewon
    Kim, Yu Kyong
    Lee, SeungHwan
    Bhatia, Siddharth
    Takanami, Yohei
    Nakaya, Ryou
    Yu, Kyung-Sang
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 138 - 144
  • [2] Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
    Zhou, Ben-Gang
    Jiang, Xin
    Ding, Yan-Bing
    She, Qiang
    Li, Yao-Yao
    [J]. HELICOBACTER, 2024, 29 (01)
  • [3] Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China
    Lu, Hong
    Zhang, Wei
    Graham, David Y.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (10) : 1134 - 1140
  • [4] Efficacy of levofloxacin, amoxicillin, bismuth-containing quadruple therapy for helicobacter pylori
    Huang, Sijing
    Wang, Chengdang
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 548 - 548
  • [5] Second line bismuth-containing quadruple therapy for Helicobacter pylori eradication in Korea
    Cho, M.
    Hwang, H.
    Kim, Y.
    Lim, C.
    Oh, J.
    [J]. HELICOBACTER, 2019, 24
  • [6] Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter pylori in Turkey
    Yozgat, Ahmet
    Kasapoglu, Benan
    Demirci, Selim
    Sokmen, Fevzi Coskun
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (07) : 490 - 493
  • [7] Comparison of vonoprazan bismuth-containing triple therapy with quadruple therapy in Helicobacter pylori-infected treatment-naive patients: a prospective multicenter randomized controlled trial
    Liang, Jing Wen
    Xiong, Si
    Jia, Ye Gui
    Xiao, Dan
    Tan, Shi Yun
    Cao, Ji Wang
    Sun, Jun
    Tian, Xia
    Li, Shu Yu
    Chen, Rui Hong
    Ruan, Gui Zhen
    Xiong, Jian Guang
    Wang, Xiao Ming
    Xu, San Ping
    Qi, Li Ping
    Liu, Yun Hua
    Zhao, Yu Chong
    Bai, Shu Ya
    Chen, Wei
    Cao, Meng Die
    Peng, Wang
    Li, Yan Ling
    Yang, Yi Lei
    Chen, Shi Ru
    Cui, Hao Chen
    Liu, Lu Yao
    Zhou, Yi
    Cheng, Bin
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024,
  • [8] COMPARISON OF THE EFFICACY OF 10 DAY-TRIPLE THERAPY-BASED, BISMUTH-CONTAINING QUADRUPLE THERAPY WITH SEQUENTIAL THERAPY OF HELICOBACTER PYLORI
    Moon, B. S.
    Yi, S. W.
    Lim, H. C.
    Lee, Y. C.
    [J]. HELICOBACTER, 2013, 18 : 131 - 131
  • [9] The efficacy of 10 day-triple therapy-based, bismuth-containing quadruple therapy for the first line therapy of Helicobacter pylori
    Moon, B. S.
    Yi, S. W.
    Lim, H. C.
    Lee, Y. C.
    [J]. HELICOBACTER, 2018, 23
  • [10] Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis
    Wu, Cheng
    Chen, Xiao
    Liu, Jing
    Li, Ming-Yang
    Zhang, Zi-Qi
    Wang, Zhi-Qiang
    [J]. HELICOBACTER, 2011, 16 (02) : 131 - 138
12345